In the US, embryo editing is barely studied, making a CRISPR baby is prohibited, and there's no startups on the scene. Yet...gene-edit tech continues to advance. Now, billionaire Brian Armstrong says he's ready to fund the defining U.S. embryo-editing company. 👇

Breaking: HHS Secretary Robert F. Kennedy Jr. says he is retiring the 17 members of a committee of government vaccine advisers. bloomberg.com/news/articles/…

Crypto billionaire Fred Ehrsam hired at least 8 people from Elon Musk's Neuralink for his new brain-tech startup Nudge, trying to build a headset that will treat diseases, improve your mood, help you sleep. What's he up to? w/Biz Carson for Bloomberg: bloomberg.com/news/articles/…

NEW: Hims won’t back down from selling copycat weight-loss shots after Novo Nordisk abruptly ended its distribution partnership. “There’s just no way in hell we’re going to cave on that," CEO andrewdudum told Bloomberg. More here from me + devin leonard: bloomberg.com/news/articles/…

Health and Human Services Secretary Robert F. Kennedy Jr.’s changes to US vaccine policy are putting the $24 billion US market for shots at risk, potentially making it harder for Americans to access them. bloomberg.com/news/articles/…

EXCLUSIVE SCOOP: Bootstrap Bio is raising seed money to work on editing the genes in reproductive cells, one of the most controversial technologies in medicine and a step toward creating designer babies. From Sophie Alexander and Ike Swetlitz bloomberg.com/news/articles/…

New: Groups representing pediatricians and health experts sued HHS Secretary Robert F. Kennedy Jr. over abrupt changes to Covid vaccine recommendations for healthy kids and pregnant women bloomberg.com/news/articles/…

SCOOP The CDC ended its emergency response for bird flu last week as the outbreak that sickened dozens of people, spread to cattle and drove up egg prices has abated bloomberg.com/news/articles/…

The second big CDC scoop in two days from Jessica Nix : The agency appointed a pro-Trump urologist to be a senior adviser. Send her more tips on Signal at username jessicanix.24! bloomberg.com/news/articles/…

FDA to Share Rejection Letters Drugmakers Often Keep Secret bloomberg.com/news/articles/…

The FDA approved Moderna's Covid vaccine for kids under 12, but only for those at increased risk. Healthy kids will likely need to get the shot off-label. bloomberg.com/news/articles/…

Scoop: FDA Commissioner Marty Makary said the agency would consider giving pharma companies expedited reviews for their medicines if they bring drug prices in line with what foreign countries pay. w/ Sam Hornblower bloomberg.com/news/articles/…

Chinese drugmakers have come a long way from their copycat days to challenge Western dominance on innovation. Our latest story visualizes this stunning advance, with data from Norstella with Jinshan Hong and Spe Chen 陳羽萱: bloomberg.com/news/features/…

Teamed up again with my colleague,Madison Muller, this time to chronicle the career and controversies of Hims & Hers CEO Andrew Dudum in the latest Businessweek. Gift-linked. Enjoy! bloomberg.com/news/features/…

Scoop: A new bill would help veterans access alternatives to opioids, part of a broader push to promote safer painkillers and reduce overdose deaths. bloomberg.com/news/articles/…

A third patient has died this year after getting a gene therapy from Sarepta. The head of the FDA tells Bloomberg that he's “taking a hard look” at whether Elevidys should remain on the market. bloomberg.com/news/articles/…

New: There were warnings to the FDA about Sarepta before US regulators asked the company to halt shipments of its gene therapy bloomberg.com/news/articles/…

New: In a major win for Sarepta, the FDA says patients who can walk are allowed to take its gene therapy again bloomberg.com/news/articles/…

Took a step back to look at the different strategies Moderna and BioNTech have taken since finding success with their Covid-19 vaccines -- and the stark divergence in their stock prices cnbc.com/2025/07/31/cov…